x
ServiziMenu principaleHome
You are here: Home > Educational Opportunities > Past events > 2021 > Eastern Europe and Balkan Region Refresher Course on Breast Cancer
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

Eastern Europe and Balkan Region Refresher Course on Breast Cancer

9 ESCO credits

23.09.2021  -  25.09.2021

Bratislava, Slovakia

REFRESHER COURSE

Description

Chairs: A. Eniu, CH – O. Pagani, CH

The Refresher Course on Breast Cancer has been designed for medical and clinical oncologists who have attended a previous edition of the Eastern Europe and Balkan Region Masterclass in Medical/Clinical Oncology and other practicing oncologists of the region with the aim to provide an update on the state-of-the-art therapeutic options as well as an overview of the latest advances in the field of breast cancer.
The programme will offer educational lectures covering updates on the diagnosis and treatment of both early and advanced breast cancer. Moreover, spotlight lectures will discuss specific issues related to particular situations such as breast cancer in young women or survivorship issues.
Practical training will be offered in the frame of clinical case presentations, prepared and presented by participants and discussed with the faculty.

LEARNING OBJECTIVES
• Update on the latest advances in diagnostic procedures
• Update on the latest advances and on the state-of- the-art treatment options
• Learn about the management of specific situations
• Debate controversies and challenges in breast cancer treatment
• Improve practical skills in multidisciplinary management and follow-up of breast cancer patients
• Receive insights on the best approaches in organizing breast cancer care (breast cancer units)

General Information

ORGANISING SECRETARIAT
Dolores Knupfer
European School of Oncology (ESO)
Piazza Indipendenza 2
6500 Bellinzona
ph +41 91 820 09 52
e-mail: dknupfer@eso.net

OFFICIAL LANGUAGE
The official language will be English. No translation will be available.

CME ACCREDITATION
An application has been made to the UEMS EACCME® for CME accreditation of this event. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

MAIN TOPICS
• Update on standard and new diagnostic, treatment options and approaches
• Signalling pathways
• Breast cancer pathology and molecular biology
• Systemic treatment of early and advanced breast cancer

PARTICIPATION
Attendance is limited to 30 participants and admittance is by competitive application only. Priority will be given to applicants who have attended a previous Eastern Europe and Balkan Region Masterclass and or those practicing in this region.

Each past masterclass participant will be able to invite one colleague to apply, and further interested medical/clinical oncologists will be able to apply too.

Applicants who have not attended a previous Eastern Europe and Balkan Region Masterclass in Medical/Clinical Oncology should meet the following profile:
• Age between 30 and 45 years
• At least 2-3 years’ experience in medical oncology
• Fluency in English
• Practicing in Eastern Europe and Balkan Region

Successful applicants are granted free registration.

Accommodation at the course venue for arrival on 23 September and departure on 25 September will be provided to participants not residing in the Bratislava area.

ESCO

Being selected to take part in an ESO Refresher course is one of the ESO activities that gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.

A Refresher also enables ESCO members to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the Refresher earns participants 9 ESCO credits.
Visit www.esco.org for information on how to join ESCO.

Application

Applications for this event are closed.

APPLICATION

Interested candidates should apply online providing:
Application template
Abstract

If a candidate is not a past participant of a previous Eastern Europe and Balkan Region Masterclass, the following documents should also be provided together with application template and abstract:

• Letter describing motivation for attending
• Short CV (template here) with the list of publications (if the list of publication is not
provided, it will be assumed that no articles have been published)

ABSTRACT

Applicants are requested to submit an abstract describing a clinical case related to breast cancer. Some admitted participants will have the opportunity to present the clinical case in the format of a clinical grand round discussion to the chairs, other faculty members and participants within plenary tumour board sessions in the programme. The application outcome will be notified by e-mail by end of June.

SUBMISSION DEADLINE: 15 June 2021

Programme

23 September

18:00Registration
19:30Dinner

24 September

7:45Registration
8:15Welcome address and general introduction
Alexandru Eniu, CH
8:30Diagnosis and local therapy
Peter Dubsky , CH - Petra Steyerova, CZ
 8:30Imaging breast cancer: from diagnosis to response evaluation
Petra Steyerova, CZ
 9:00Molecular biology and traditional pathology: hand in hand
Giancarlo Pruneri, IT
 9:30Breast cancer surgery: Understanding when less is more for the patient (including reconstruction)
Peter Dubsky , CH
 10:00Personalized radiotherapy: more, less or differently?
Antonella Richetti, CH
10:30Coffee break
11:00Systemic therapy of early breast cancer
Alexandru Eniu, CH - Olivia Pagani, CH
 11:00Optimizing strategy of adjuvant hormonal therapy in pre-and postmenopausal early breast cancer
Olivia Pagani, CH
 11:30Adjuvant chemotherapy in luminal breast cancer: who needs it, and how much?
Giuseppe Curigliano, IT
 12:00Update on HER2-directed and cytotoxic adjuvant therapy
Giuseppe Curigliano, IT
 12:30Making best use of neoadjuvant systemic therapy in locally advanced breast cancer
Alexandru Eniu, CH
13:15Lunch
14:15Treatment of metastatic disease
Giuseppe Curigliano, IT - Olivia Pagani, CH
 14:15Optimizing the treatment sequence of systemic therapy in triple negative and HER2 positive breast cancer
Giuseppe Curigliano, IT
 14:45Are we better in treating hormone-responsive metastatic breast cancer in 2020?- Role of CDK 4/6 among the classical hormonal interventions
Olivia Pagani, CH
 15:45Oligometastatic disease hoping for cure or just a sophisticated palliation?
Alexandru Eniu, CH - Antonella Richetti, CH
16:10Coffee break
16:30Tumour board: selected clinical cases presented by participants and discussed by the panel
Giuseppe Curigliano, IT - Peter Dubsky , CH - Alexandru Eniu, CH - Olivia Pagani, CH - Antonella Richetti, CH - Petra Steyerova, CZ
19:00Dinner

25 September

8:30Particular issues in breast cancer management
Giuseppe Curigliano, IT - Olivia Pagani, CH
 8:30Keynote lecture: New therapeutic approaches for breast cancer: established signaling pathways and immune therapy
Giuseppe Curigliano, IT
 9:00Breast Cancer in Young Women: specific recommendations, fertility, and pregnancy
Olivia Pagani, CH
 9:30Survivorship issues in both early and advanced breast cancer patients
Olivia Pagani, CH
 10:00Keynote lecture Integrating multidisciplinarity: the concept of the breast units and multidisciplinary care
Alexandru Eniu, CH
10:30Coffee break
11:00Tumour board: selected clinical cases presented by participants and discussed by the panel
Giuseppe Curigliano, IT - Alexandru Eniu, CH - Olivia Pagani, CH
11:45Closing remarks
Alexandru Eniu, CH - Olivia Pagani, CH

Faculty

Giuseppe Curigliano, European Institute of Oncology / University of Milan, New Drugs for Innovative Therapies Division, Milano, IT
Peter Dubsky, Hirslanden St. Anna Clinic, Breast Unit, Lucerne, CH
Alexandru Eniu, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Olivia Pagani, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Giancarlo Pruneri, National Cancer Institute, IRCCS Foundation, Pathology Dpt., Milano, IT
Antonella Richetti, Oncology Institute of Southern Switzerland (IOSI), Radiation Oncology Dept., Bellinzona, CH
Petra Steyerova, General University Hospital Prague, Clinic of Radiology, Breast Cancer screening and diagnostic center, Prague 2, CZ